Aurigene Oncology Limited (formerly, Aurigene Discovery Technologies Limited) is a clinical stage biotech company committed to bringing novel therapeutics for the treatment of cancer. Based in Bengaluru and Kuala Lumpur, Aurigene is focused on developing innovative therapeutics addressing several hallmarks of cancer and has built comprehensive drug discovery and development capabilities, nurtured a growing team of passionate scientists, and collaborated with partners from across the world. Over the past two decades Aurigene has contributed to delivering 18 novel chemical entities which are currently in clinical development. Aurigene has also out-licensed several first-in-class and best-in-class compounds to pharma and biotech companies for global clinical development, while undertaking clinical POC studies for a few programs on its own. For more information, please visit Aurigene’s website at www.aurigene.com.
View Top Employees from Aurigene Discovery TechnologiesLooking for a particular Aurigene Discovery Technologies employee's phone or email?
The Aurigene Discovery Technologies annual revenue was $100 million in 2024.
Nanduri Srinivas is the Senior Director of Aurigene Discovery Technologies.
617 people are employed at Aurigene Discovery Technologies.
Aurigene Discovery Technologies is based in Bangalore, Karnataka.
The NAICS codes for Aurigene Discovery Technologies are [541, 541711, 5417, 54171, 54].
The SIC codes for Aurigene Discovery Technologies are [283, 28, 80].